BROKERS CHOICE: HCLTECH, INFOEDGE, BAJAJCONS, BELRISE, LEMONTREE, DRREDDY, MAZDOCK, BEML, ASTRAL, HINDALCO

AHMEDABAD, 12 AUGUST: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on HCL tech: Maintain Buy on Company, target price at Rs 1850 (Positive)

HSBC on Info Edge: Upgrade to Buy on Company, raise target price at Rs 1670 (Positive)

Nuvama on Bajaj Consumer: Maintain Buy on Company, target price at Rs 274 (Positive)

Jefferies on Belrise: Maintain Buy on Company, target price at Rs 135 (Positive)

Macquarie on Lemon Tree: Maintain Outperform on Company, target price at Rs 200 (Positive)

Nuvama on AMCs: Sees record ₹56,540 cr equity inflows in July, bullish on HDFCAMC & NAM for earnings rebound (Positive)

Citi on Pharma: USFDA has approved two generic versions of Iron Sucrose & both may be eligible for 180-days of CGT exclusivity. Among Indian generics, Iron Sucrose was an important pipeline product for Dr Reddy’s & Aurobindo Pharma (Neutral)

Antique on BEML: Maintain Buy on Company, cut target price at Rs 4921 (Neutral)

MOSL on Nippon AMC: Maintain Buy on Company, target price at Rs 930 (Neutral)

Jefferies on Entero: Maintain Hold on Company, target price at Rs 1350 (Neutral)

Citi on Concord: Maintain Neutral on Company, target price at Rs 1880 (Neutral)

MS on Titagarh Rail: Maintain Overweight on Company, target price at Rs 1027 (Neutral)

MS on Astral: Maintain Equal weight on Company, target price at Rs 1489 (Neutral)

CLSA on Astral: Maintain Hold on Company, target price at Rs 1515 (Neutral)

Jefferies on Hindalco: Maintain Hold on Company, target price at Rs 690 (Neutral)

CLSA on Hindalco: Maintain Outperform on Company, target price at Rs 850 (Neutral)

Nuvama on Hindalco: Maintain Buy on Company, target price at Rs 776 (Neutral)

Listing of Highway Infrastructure

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)